Closing the Affordability Gap in Real Time
November 25, 2025
Stephen serves as Chief Operating Officer of RIS Rx, which he co-founded in 2020. Stephen manages all aspects of operations in RIS Rx's patient affordability and gross-to-net (GTN) revenue protection solutions for pharma manufacturers, routinely combining his deep knowledge as a frontline pharmacist with scalable tech-enabled workflows. He earned his PharmD from Loma Linda University.
"*" indicates required fields
RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.